In this presentation from the ESMO 18th World Congress on Gastrointestinal Cancer, Dr. Ramon Salazar examines whether gene signatures are ready for use in the selection of patients for adjuvant treatment.
Are gene signatures ready for use in the selection of patients for adjuvant treatment?
